The immunohistochemistry (IHC) market is on a promising growth trajectory, with an anticipated value of USD 3.5 billion in ...

The Global Cytogenetics Market is estimated to be valued at approximately USD 2.42 billion in 2023 and is expected to grow at a robust CAGR of 9.5% over the forecast period 2024-2032. Request To ...

The company is targeting its RPPA-based testing to biopharma firms as well as for clinical trial work and to clinicians to help guide therapy in cancer patients.

Allied Market Research published a report, titled, "Breast Cancer Screening Market by Test Type (Blood Marker Test, Genetic Test, Imaging Test and Immunohistochemistry Test), by Gender (Male and ...

Melanoma-associated antigen A6 (MAGEA6) is well known to have oncogenic activity, but the underlying mechanisms by which it regulates tumor progression and chemo-resistance, especially in ...

Immunoblotting and immunohistochemistry confirmed the loss of CDK12 protein. To describe more explicitly how the loss of ...

Siriraj Hospital excels in maintaining its high standards for every service, including diagnostics through the integration of cutting-edge technology into its medical services, furthering its mission ...

How have immunohistochemistry and immunofluorescence been adapted to fit the growing needs of the life science research ...

The firm sees potential for AI algorithms to support drug development by screening patients for biomarkers and predicting their responses to cancer therapies.